Outbreak of an Uncommon Rifampin-resistant blaNDM-1Citrobacter amalonaticus Strain in a Digestive Rehabilitation Center: The Putative Role of Rifaximin - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Clinical Infectious Diseases Year : 2020

Outbreak of an Uncommon Rifampin-resistant blaNDM-1Citrobacter amalonaticus Strain in a Digestive Rehabilitation Center: The Putative Role of Rifaximin

Fréderic Fourreau
  • Function : Author
Camille Gomart
  • Function : Author
Audrey Maurand
  • Function : Author
Bruno Hacquin
  • Function : Author
David Ducellier
  • Function : Author
Florence Cizeau
  • Function : Author
Stéphane Lo
  • Function : Author
Catherine Cordonnier-Jourdin
  • Function : Author
Mélanie Mercier-Darty
  • Function : Author
Jean-Winoc Decousser
  • Function : Author

Abstract

Abstract We describe a sudden 2-week outbreak due to a blaNDM-1Citrobacter amalonaticus strain in a 22-bed digestive rehabilitation center. Three of the 5 colonized patients received long-term rifaximin treatment to prevent hepatic encephalopathy. The strains were genotypically identical, phenotypically resistant to rifampin, and harbored arr-3, a rifampin adenosine diphosphate-ribosyl transferase.

Dates and versions

hal-04283230 , version 1 (13-11-2023)

Identifiers

Cite

Guilhem Royer, Fréderic Fourreau, Camille Gomart, Audrey Maurand, Bruno Hacquin, et al.. Outbreak of an Uncommon Rifampin-resistant blaNDM-1Citrobacter amalonaticus Strain in a Digestive Rehabilitation Center: The Putative Role of Rifaximin. Clinical Infectious Diseases, 2020, 71 (5), pp.1331-1333. ⟨10.1093/cid/ciz1172⟩. ⟨hal-04283230⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More